NuvOx LLC
NuvOx LLC
Explore linked clinical trials.4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 2 | 2026-08-06 | NCT03862430 | |
| Liquid Biopsy in Glioblastoma Treated With Chemoradiation and an Oxygen Therapeutic | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Enrolling by invitation | Not stated | 2026-02-18 | NCT07417774 | |
| A Dose Escalation Study of NanO2 in Patients With Mild Respiratory Distress | Dyspnea, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Signs and Symptoms, Signs and Symptoms, Respiratory, respiratory system disorder | Recruiting | Phase 1 | 2026-01-28 | NCT06658535 | |
| NanO2 in Large VessEL Occlusion Stroke (NOVEL) | brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, stroke disorder, vascular disorder | Not yet recruiting | Phase 2 | 2025-04-04 | NCT06821347 |